Histogen (HSTO) Competitors $0.0002 0.00 (0.00%) As of 10/22/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock HSTO vs. AMPE, CMRA, EFTR, PXMD, ATNFW, LBPSW, AIMDW, ALVOW, ARAV, and ACABWShould you be buying Histogen stock or one of its competitors? The main competitors of Histogen include Ampio Pharmaceuticals (AMPE), Comera Life Sciences (CMRA), eFFECTOR Therapeutics (EFTR), PaxMedica (PXMD), 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Ainos (AIMDW), Alvotech (ALVOW), ARAVIVE (ARAV), and Atlantic Coastal Acquisition Corp. II (ACABW). These companies are all part of the "pharmaceutical products" industry. Histogen vs. Its Competitors Ampio Pharmaceuticals Comera Life Sciences eFFECTOR Therapeutics PaxMedica 180 Life Sciences 4D pharma Ainos Alvotech ARAVIVE Atlantic Coastal Acquisition Corp. II Ampio Pharmaceuticals (NYSE:AMPE) and Histogen (NASDAQ:HSTO) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, profitability, valuation, dividends and institutional ownership. Which has higher valuation & earnings, AMPE or HSTO? Ampio Pharmaceuticals has higher earnings, but lower revenue than Histogen. Ampio Pharmaceuticals is trading at a lower price-to-earnings ratio than Histogen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmpio PharmaceuticalsN/AN/A-$8.63M-$11.010.00Histogen$19K0.04-$10.62M-$2.810.00 Does the media refer more to AMPE or HSTO? In the previous week, Ampio Pharmaceuticals' average media sentiment score of 0.00 equaled Histogen'saverage media sentiment score. Company Overall Sentiment Ampio Pharmaceuticals Neutral Histogen Neutral Do insiders and institutionals have more ownership in AMPE or HSTO? 5.7% of Ampio Pharmaceuticals shares are held by institutional investors. 3.3% of Ampio Pharmaceuticals shares are held by company insiders. Comparatively, 3.3% of Histogen shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has more volatility and risk, AMPE or HSTO? Ampio Pharmaceuticals has a beta of 5.13, suggesting that its share price is 413% more volatile than the S&P 500. Comparatively, Histogen has a beta of 1.19, suggesting that its share price is 19% more volatile than the S&P 500. Is AMPE or HSTO more profitable? Company Net Margins Return on Equity Return on Assets Ampio PharmaceuticalsN/A N/A N/A Histogen N/A N/A N/A SummaryAmpio Pharmaceuticals and Histogen tied by winning 3 of the 6 factors compared between the two stocks. Get Histogen News Delivered to You Automatically Sign up to receive the latest news and ratings for HSTO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HSTO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart HSTO vs. The Competition Export to ExcelMetricHistogenPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1K$1.02B$6.14B$10.76BDividend YieldN/A4.84%5.71%4.83%P/E Ratio0.001.3429.8028.54Price / Sales0.04165.12499.08189.72Price / CashN/A17.6336.6160.67Price / Book0.007.7012.016.60Net Income-$10.62M-$7.58M$3.32B$276.82M7 Day PerformanceN/A1.62%1.59%1.99%1 Month PerformanceN/A26.46%6.15%2.56%1 Year PerformanceN/A-14.24%61.11%32.85% Histogen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSTOHistogenN/A$0.00flatN/A-99.9%$1K$19K0.0020AMPEAmpio PharmaceuticalsN/A$0.00+14.8%N/A+40.9%$4KN/A0.0020Gap UpCMRAComera Life SciencesN/AN/AN/AN/A$3K$1.00M0.002EFTReFFECTOR Therapeutics0.1789 of 5 stars$0.00flatN/A-83.3%$1KN/A0.0010Upcoming EarningsPXMDPaxMedicaN/A$0.00flatN/A-99.9%$1KN/A0.002ATNFW180 Life SciencesN/A$0.04-5.0%N/A+264.5%$0.00N/A0.007Gap UpLBPSW4D pharmaN/AN/AN/AN/A$0.00$522K0.00N/AAIMDWAinosN/A$0.15-15.3%N/AN/A$0.00$110.87K0.0040ALVOWAlvotechN/A$1.82+7.7%N/A-39.3%$0.00$560.10M0.004Gap DownARAVARAVIVEN/A$0.04flatN/AN/A$0.00$9.14M0.0020High Trading VolumeACABWAtlantic Coastal Acquisition Corp. IIN/A$0.02-5.7%N/A-47.8%$0.00N/A0.0015 Related Companies and Tools Related Companies Ampio Pharmaceuticals Competitors Comera Life Sciences Competitors eFFECTOR Therapeutics Competitors PaxMedica Competitors 180 Life Sciences Competitors 4D pharma Competitors Ainos Competitors Alvotech Competitors ARAVIVE Competitors Atlantic Coastal Acquisition Corp. II Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSTO) was last updated on 10/24/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredFree: The Crypto Summit That Could Change Your LifeFed cuts unleash crypto's next wave The smart money is already moving. This is your chance to see their car...Crypto 101 Media | SponsoredMiss This IRS Strategy Now, Regret It LaterWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | Sponsored$4,200 gold is nice ... but here’s what most gold bugs are missingGold just surged past $4,200, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | SponsoredElon Musk is on the lineElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Histogen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Histogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HSTO Stock Alerts